PPARδ agonist is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-08. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
1H + 16O → 13N + 4He In this endothermic reaction, the proton must be accelerated to have a total energy greater than 5.66 MeV. The presence of ethanol allows the formation of ammonia as nitrogen-13 is produced. Other routes of producing 13N-labelled ammonia exist, some of which facilitate co-generation of other light radionuclides for diagnostic imaging.
==== Jasmine ==== Marika Reimon (礼紋 茉莉花, Reimon Marika), also known as "Jasmine" (ジャスミン, Jasumin), is a calm and collected psychic, or "ESPer", who serves as Deka Yellow (デカイエロー, Deka Ierō). In the past, she suffered from depression over her then-inability to control her abilities and contemplated suicide by allowing an Alienizer to kill her. However, she was rescued and recruited by Doggie Kruger. In the present, she is good friends with her teammate Umeko, with whom she forms a tag-team called the Twin Cam Angels (ツインカム・エンジェル, Tsuin Kamu Enjeru). As of the direct-to-video anniversary special Tokusou Sentai Dekaranger: 10 Years After, Jasmine is married and has a son named Taiga (大我). Jasmine's ESPer abilities allow her to pick up on sensory impressions of others by handling an object connected to them or visiting a location her target has been to, though overuse of her powers exhausts her. To control her powers, she wears gloves. Furthermore, as a result of breast-feeding her son during the direct-to-video anniversary special Tokusou Sentai Dekaranger: 10 Years After, Jasmine temporarily gained the ability to teleport herself to any part of the universe, which she loses as of the direct-to-video anniversary special Tokusou Sentai Dekaranger 20th: Fireball Booster. In the crossover film Mahō Sentai Magiranger vs. Dekaranger, she displays the ability to break the fourth wall.
== Further reading == He, Ran; Cao, Jie; Tan, Tieniu (2025). "Generative Artificial Intelligence: A Historical Perspective". National Science Review. 12 (5) nwaf050. doi:10.1093/nsr/nwaf050. PMC 11970245. PMID 40191253. James Gleick, "The Parrot in the Machine" (review of Emily M. Bender and Alex Hanna, The AI Con: How to Fight Big Tech's Hype and Create the Future We Want, Harper, 274 pp.; and James Boyle, The Line: AI and the Future of Personhood, MIT Press, 326 pp.), The New York Review of Books, vol. LXXII, no. 12 (24 July 2025), pp. 43–46. "[C]hatbox 'writing' has a bland, regurgitated quality. Textures are flattened, sharp edges are sanded. No chatbox could ever have said that April is the cruelest month or that fog comes on little cat feet (though they might now, because one of their chief skills is plagiarism). And when synthetically extruded text turns out wrong, it can be comically wrong. When a movie fan asked Google whether a certain actor was in Heat, he received this 'AI Overview': 'No, Angelina Jolie is not in heat.'" (p. 44.)
The structure and function of the GI tract can be described both by gross anatomy and microscopic anatomy (histology). The tract itself is divided into upper and lower tracts, and the intestines into small and large intestines.
Sources: en.wikipedia.org
Tyne and Wear contains green belt interspersed throughout the county, mainly on the fringes of the Tyneside/Wearside conurbation. There is also an inter-urban line of belt helping to keep the districts of South Tyneside, Gateshead, and Sunderland separated. It was first drawn up from the 1950s. All the county's districts contain some portion of belt.
== Clinical Significance == Many diseases such as Human African trypanosomiasis, Nagana disease in cattle, and Chagas disease are caused by kinetoplastid parasites. Such diseases infect an estimated 15 to 20 million people per year worldwide and kill 100000 to 150000 of those infected. Current treatments for these diseases were generally made almost 100 years ago and in that time many of the parasites have developed resistance, in addition, many of the original treatments are highly toxic. Targeting trypanothione synthase could be a novel way of preventing and curing these diseases through disruption of the parasites' metabolism. Scientists believe that the thiol metabolic pathway is an especially good target for anti-parasitic drug production as trypanothione based thiol redox is absent in humans and it is thought that thiol redox is key in the mechanisms some parasites have in order to obtain drug resistance .
=== Ribosomes make proteins === In the 1950s, results of labeling experiments in rat liver showed that radioactive amino acids were found to be associated with "microsomes" (later redefined as ribosomes) very rapidly after administration, and before they became widely incorporated into cellular proteins. Ribosomes were first visualized using electron microscopy, and their ribonucleoprotein components were identified by biophysical methods, chiefly sedimentation analysis within ultracentrifuges capable of generating very high accelerations (equivalent to hundreds of thousands times gravity). Polysomes (multiple ribosomes moving along a single mRNA molecule) were identified in the early 1960s, and their study led to an understanding of how ribosomes read the mRNA in a 5′ to 3′ direction, generating proteins as they do so.
Cheat Mountain (Snowshoe Mountain) at Thorny Flat 4,848 ft (1,478 m) and Bald Knob 4,842 ft (1,476 m) are among the more notable peaks in West Virginia. The Blue Ridge Mountains, rising in southern Pennsylvania and there known as South Mountain, attain elevations of about 2,000 ft (600 m) in Pennsylvania. South Mountain achieves its highest point just below the Mason-Dixon line in Maryland at Quirauk Mountain 2,145 ft (654 m) and then diminishes in height southward to the Potomac River. Once in Virginia, the Blue Ridge again reaches 2,000 ft (600 m) and higher. In the Virginia Blue Ridge, the following are some of the highest peaks north of the Roanoke River: Stony Man 4,031 ft (1,229 m), Hawksbill Mountain 4,066 ft (1,239 m), Apple Orchard Mountain 4,225 ft (1,288 m) and Peaks of Otter 4,001 and 3,875 ft (1,220 and 1,181 m). South of the Roanoke River, along the Blue Ridge, are Virginia's highest peaks including Whitetop Mountain 5,520 ft (1,680 m) and Mount Rogers 5,729 ft (1,746 m), the highest point in the Commonwealth. Chief summits in the southern section of the Blue Ridge are located along two main crests, the Western or Unaka Front along the Tennessee-North Carolina border and the Eastern Front in North Carolina, or one of several "cross ridges" between the two main crests.
== Skyscrapers == The German building research firm Emporis ranks world cities by the number of their skyscrapers. Emporis defines a skyscraper as "...any multilevel building with an architectural height of at least 100 metres." Bangkok ranks number seven of the 100 cities with the most skyscrapers. Bangkok has 376. Other ASEAN cities listed are Singapore, ranked 4 with 506 skyscrapers; Kuala Lumpur, ranked 14 with 202; Jakarta, ranked 17 with 181; Hanoi, ranked 36 with 120; Ho Chi Minh City, ranked 43 with 103; and Manila, ranked 93 with 37 skyscrapers.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.